Author Correction: MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial.
Jennifer M. Mitchell, Marcela Ot’alora G, Bessel Van der Kolk, Scott Shannon, Michael Bogenschutz, Yevgeniy Gelfand, Casey Paleos, Christopher R. Nicholas, Sylvestre Quevedo, Brooke Balliett, Scott Hamilton, Michael Mithoefer, Sarah Kleiman, Kelly Parker-Guilbert, Keren Tzarfaty, Charlotte Harrison, Alberdina De Boer, Rick Doblin, Berra Yazar-Klosinski
Nat Med November 1, 2024 DOI: 10.1038/s41591-024-03331-w via PubMed Central
Study at a glance
| Characteristics | Randomized Placebo-controlled Peer reviewed |
|---|---|
| Topics | Psychedelic-assisted therapy |
| Keywords | PTSD Treatment Trauma therapy PTSD Relief Trauma recovery Mental health treatment |
| Citations | 4 |
Abstract
In the version of the article initially published, some members of the MAPP2 Study Collaborator Group were listed only in the Supplementary Information. Charlotte Harrison, Berra Yazar-Klosinski, Wael Garas, Darrick May, Cole Marta, Susan Walker, Elizabeth Nielson, Gregory Wells, Randall Brown, Revital Amiaz, Yair Wallach, Ray Worthy, Alia Lilienstein and Amy Emerson have now been added to the main list of collaborators in the HTML and PDF versions of the article.